Jens Wiltfang

Active 1987–2026

260
Papers
28,686
Citations
91
h-index
232
i10-index

Citations

Citations per year for Jens Wiltfang1986: 1 citations1989: 3 citations1990: 1 citations1991: 4 citations1992: 5 citations1993: 2 citations1994: 3 citations1995: 7 citations1996: 2 citations1997: 5 citations1998: 19 citations1999: 25 citations2000: 48 citations2001: 58 citations2002: 72 citations2003: 102 citations2004: 117 citations2005: 117 citations2006: 170 citations2007: 165 citations2008: 174 citations2009: 251 citations2010: 299 citations2011: 346 citations2012: 358 citations2013: 296 citations2014: 386 citations2015: 341 citations2016: 336 citations2017: 303 citations2018: 311 citations2019: 896 citations2020: 989 citations2021: 1,011 citations2022: 853 citations2023: 694 citations2024: 1,099 citations2025: 600 citations2026: 31 citations1987–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,393 citing papers, 21.4% of this breakdownGermany: 1,489 citing papers, 9.4% of this breakdownUnited Kingdom: 1,390 citing papers, 8.8% of this breakdownChina: 1,063 citing papers, 6.7% of this breakdownItaly: 670 citing papers, 4.2% of this breakdownSweden: 661 citing papers, 4.2% of this breakdownNetherlands: 596 citing papers, 3.7% of this breakdownFrance: 528 citing papers, 3.3% of this breakdownSpain: 522 citing papers, 3.3% of this breakdownCanada: 501 citing papers, 3.2% of this breakdownAustralia: 479 citing papers, 3% of this breakdownSwitzerland: 401 citing papers, 2.5% of this breakdown
0%21.4%Other 26.3%

Fields

  • Medicine57.9%
  • Biochemistry, Genetics and Molecular Biology17.4%
  • Neuroscience15.3%
  • Engineering1.8%
  • Immunology and Microbiology1.2%
  • Psychology1.1%
  • Other5.3%

Topics

  • Alzheimer's disease research and treatments15%
  • Dementia and Cognitive Impairment Research7.4%
  • Neuroinflammation and Neurodegeneration Mechanisms4.1%
  • Cholinesterase and Neurodegenerative Diseases2.3%
  • Functional Brain Connectivity Studies1.9%
  • Computational Drug Discovery Methods1.9%
  • Other67.4%

Coauthors

All papers

Open in search
  1. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Mann, A. David Smith, Seth Love, Patrick G. Kehoe, John Hardy, Simon Mead, Nick C. Fox, Martin N. Rossor, John Collinge, Wolfgang Maier, Frank Jessen, Britta Schürmann, Reinhard Heun, Hendrik van den Bussche, Isabella Heuser, Johannes Kornhuber, Jens Wiltfang, Martin Dichgans, Lutz Frölich, Harald Hampel, Michael Hüll, Dan Rujescu, Alison Goate, John S.K. Kauwe, Carlos Cruchaga, Petra Nowotny, John C. Morris, Kevin H. Mayo, Kristel Sleegers, Karolien Bettens, Sebastiaan Engelborghs, Peter Paul De Deyn, Christine Van Broeckhoven, Gill Livingston, Nicholas Bass, Hugh Gurling, Andrew McQuillin, Rhian Gwilliam, Panagiotis Deloukas, Ammar Al‐Chalabi, Christopher E. Shaw, Magda Tsolaki, Andrew B. Singleton, Rita Guerreiro, Thomas W. Mühleisen, Markus M. Nöthen, Susanne Moebus, Karl‐Heinz Jöckel, Norman Klopp, H‐Erich Wichmann, Minerva M. Carrasquillo, V. Shane Pankratz, Steven G. Younkin, Peter Holmans, Michael O‘Donovan, Michael J. Owen, Julie Williams - Nature Genetics 2009 cited by 3,398

  2. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Craig, Bernadette McGuinness, Stephen Todd, Clive Holmes, David Mann, A. David Smith, Helen Beaumont, Donald Warden, Gordon Wilcock, Seth Love, Patrick G. Kehoe, Nigel M. Hooper, Emma Vardy, John Hardy, Simon Mead, Nick C. Fox, Martin N. Rossor, John Collinge, Wolfgang Maier, Frank Jessen, Eckart Rüther, Britta Schürmann, Reiner Heun, Heike Kölsch, Hendrik van den Bussche, Isabella Heuser, Johannes Kornhuber, Jens Wiltfang, Martin Dichgans, Lutz Frölich, Harald Hampel, John Gallacher, Michael Hüll, Dan Rujescu, Ina Giegling, Alison Goate, John Kauwe, Carlos Cruchaga, Petra Nowotny, John C. Morris, Kevin H. Mayo, Kristel Sleegers, Karolien Bettens, Sebastiaan Engelborghs, Peter Paul De Deyn, Christine Van Broeckhoven, Gill Livingston, Nicholas Bass, Hugh Gurling, Andrew McQuillin, Rhian Gwilliam, Panagiotis Deloukas, Ammar Al‐Chalabi, Christopher E. Shaw, Magda Tsolaki, Andrew B. Singleton, Rita Guerreiro, Thomas W. Mühleisen, Markus M. Nöthen, Susanne Moebus, Karl‐Heinz Jöckel, Norman Klopp, H‐Erich Wichmann, V. Shane Pankratz, Sigrid Botne Sando, Jan Aasly, Maria Barcikowska, Zbigniew K. Wszołek, Dennis W. Dickson, Neill R. Graff‐Radford and 73 more - Nature Genetics 2011 cited by 2,083

  3. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Niels Hansen, Mathias Bähr, Inga Zerr, Agnes Flöel, Peter J. Nestor, Emrah Düzel, Wenzel Glanz, Enise I. Incesoy, Katharina Bürger, Daniel Janowitz, Robert Perneczky, Boris‐Stephan Rauchmann, Franziska Hopfner, Olivia Wagemann, Johannes Levin, Stefan Teipel, Ingo Kilimann, Doreen Göerß, Johannes Prudlo, Thomas Gasser, Kathrin Brockmann, David Mengel, Milan Zimmermann, Matthis Synofzik, Carlo Wilke, Judit Selma‐González, Janina Turón‐Sans, Miguel Santos‐Santos, Daniel Alcolea, Sara Rubio‐Guerra, Juan Fortea, Álvaro Carbayo, Alberto Lleó, Ricardo Rojas‐García, Ignacio Illán‐Gala, Michael Wagner, Ingo Frommann, Sandra Roeske, L Bertram, Michael T. Heneka, Frederic Brosseron, Alfredo Ramı́rez, Matthias Schmid, Rudi Beschorner, Annett Halle, Jochen Herms, Manuela Neumann, Nicolas R. Barthélemy, Randall J. Bateman, Patrizia Rizzu, Peter Heutink, Oriol Dols‐Icardo, Günter U. Höglinger, Andreas Hermann, Anja Schneider - Nature Medicine 2024 cited by 185

  4. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer s Research & Therapy 2018 cited by 257

  5. Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raquel Sánchez‐Valle, Victoria Álvarez, Merçé Boada, Pablo García‐González, Raquel Puerta, Pablo Mir, Luís Miguel Real, Gerard Piñol‐Ripoll, José María García‐Alberca, José Luís Royo, Eloy Rodríguez‐Rodríguez, Hilkka Soininen, Teemu Kuulasmaa, Alexandre de Mendonça, Shima Mehrabian, Jakub Hort, Martin Vyhnálek, Sven J. van der Lee, Caroline Graff, Goran Papenberg, Vilmantas Giedraitis, Anne Boland, Delphine Bacq‐Daian, Jean‐François Deleuze, Gaël Nicolas, Carole Dufouil, Florence Pasquier, Olivier Hanon, Stéphanie Debette, Edna Grünblatt, Julius Popp, Luisa Benussi, Daniela Galimberti, Beatrice Arosio, Patrizia Mecocci, Vincenzo Solfrizzi, Lucilla Parnetti, Alessio Squassina, Lucio Tremolizzo, Barbara Borroni, Benedetta Nacmias, Sandro Sorbi, Paolo Caffarra, Davide Seripa, Innocenzo Rainero, Antonio Daniele, Carlo Masullo, Gianfranco Spalletta, Julie Williams, Philippe Amouyel, Frank Jessen, Patrick G. Kehoe, Magda Tsolaki, Giacomina Rossi, Pascual Sánchez‐Juan, Kristel Sleegers, Martin Ingelsson, Ole A. Andreassen, Mikko Hiltunen, Cornelia M. van Duijn, Rebecca Sims, Wiesje M. van der Flier, Agustı́n Ruiz, Alfredo Ramı́rez, Jean‐Charles Lambert, Ruth Frikke‐Schmidt - JAMA Network Open 2023 cited by 93

  6. Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ruth Frikke‐Schmidt, Julie Williams, Agustı́n Ruiz, Jean‐Charles Lambert, Michael D. Greicius, Members of the EADB, GR@ACE, DEGESCO, DemGene, GERAD, and EADI Groups, Beatrice Arosio, Luisa Benussi, Anne Boland, Barbara Borroni, Paolo Caffarra, Delphine Daian, Antonio Daniele, Stéphanie Debette, Carole Dufouil, Emrah Düzel, Daniela Galimberti, Vilmantas Giedraitis, Timo Grimmer, Caroline Graff, Edna Grünblatt, Olivier Hanon, Lucrezia Hausner, Stefanie Heilmann‐Heimbach, Henne Holstege, Jakub Hort, Jürgen Deckert, Teemu Kuulasmaa, Aad van der Lugt, Carlo Masullo, Patrizia Mecocci, Shima Mehrabian, Alexandre de Mendonça, Susanne Moebus, Benedetta Nacmias, Gaël Nicolas, Robert Olaso, Goran Papenberg, Lucilla Parnetti, Florence Pasquier, Oliver Peters, Yolande A.L. Pijnenburg, Julius Popp, Innocenzo Rainero, Inez Ramakers, Steffi G. Riedel‐Heller, Nikolaos Scarmeas, Philip Scheltens, Norbert Scherbaum, Anja Schneider, Davide Seripa, Hilkka Soininen, Vincenzo Solfrizzi, Gianfranco Spalletta, Alessio Squassina, John C. van Swieten, Thomas Tegos, Lucio Tremolizzo, Frans Verhey, Martin Vyhnálek, Jens Wiltfang, Merçé Boada, Pablo García‐González, Raquel Puerta, Luís Miguel Real, Victoria Álvarez, María J. Bullido, Jordi Clarimón, José María García‐Alberca, Pablo Mir and 10 more - JAMA Neurology 2022 cited by 93

  7. Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raquel Lemos, Sebastiaan Engelborghs, Stefan Van der Mussele, The Alzheimer’s Disease Neuroimaging Initiative, Yvonne Freund‐Levi, Åsa K. Wallin, Harald Hampel, Wiesje M. van der Flier, Philip Scheltens, Pieter Jelle Visser - Brain 2015 cited by 393

  8. Oligodendrocytes produce amyloid-β and contribute to plaque formation alongside neurons in Alzheimer’s disease model mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oliver Wirths, Jens Wiltfang, Sarah Jäkel, Riqiang Yan, Klaus‐Armin Nave - Nature Neuroscience 2024 cited by 101

  9. Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nina Roy, Klaus Scheffler, Anja Schneider, Annika Spottke, Eike Jakob Spruth, Stefan Teipel, Ruth Vukovich, Jens Wiltfang, Frank Jessen, Michael Wagner, on behalf of the DELCODE Study Group - Neurology 2021 cited by 159

  10. Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Renat Yakupov, Anne‐Sophie Weyrauch, Gabriel Ziegler, Matthias Schmid, Christoph Laske, Robert Perneczky, Anja Schneider, Jens Wiltfang, Stefan Teipel, Katharina Bürger, Josef Priller, Oliver Peters, Alfredo Ramı́rez, Henning Boecker, Michael T. Heneka, Michael Wagner, Emrah Düzel - Alzheimer s & Dementia 2022 cited by 109

  11. Effect of Minocycline on Depressive Symptoms in Patients With Treatment-Resistant Depression

    Authors: , , , , , , , , , , , , , , , , , , - JAMA Network Open 2022 cited by 89

  12. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gunilla Johansson, Natalia Ermann, John Q. Trojanowski, Ilker Karaca, Holger Wagner, Patrick Oeckl, Linda van Waalwijk van Doorn, Maria Bjerke, Dimitrios Kapogiannis, H. Bea Kuiperij, Lucia Farotti, Yi Li, Brian A. Gordon, Stéphane Epelbaum, Stephanie J. B. Vos, Catharina J.M. Klijn, William E. Van Nostrand, Carolina Minguillón, Matthias Schmitz, Carla Gallo, Andrea Lopez Mato, Florence Thibaut, Simone Lista, Daniel Alcolea, Henrik Zetterberg, Kaj Blennow, Johannes Kornhuber, on Behalf of the Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut - The World Journal of Biological Psychiatry 2017 cited by 318

  13. Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer's disease.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anja Schneider, Björn H. Schott, Annika Spottke, Eike Spruth, Marc‐An dré Weber, Birgit Ertl‐Wagner, Michael Wagner, Jens Wiltfang, Frank Jessen, Stefan Teipel, ADNI - 2021 cited by 65

  14. The mechanism of γ‐Secretase dysfunction in familial Alzheimer disease

    Authors: , , , , , , , , , , , , , , , , , - The EMBO Journal 2012 cited by 500

  15. Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christoph Laske, Matthias H. Munk, Emrah Düzel, Renat Yakupow, Laura Dobisch, Coraline D. Metzger, Wenzel Glanz, Michael Ewers, Peter Dechent, John­–Dylan Haynes, Klaus Scheffler, Nina Roy, Ayda Rostamzadeh, Annika Spottke, Alfredo Ramı́rez, David Mengel, Matthis Synofzik, Mathias Jucker, Eicke Latz, Frank Jessen, Michael Wagner, Michael T. Heneka, the DELCODE study group - Alzheimer s Research & Therapy 2023 cited by 55

  16. Glycoprotein NMB: a novel Alzheimer’s disease associated marker expressed in a subset of activated microglia

    Authors: , , , , , , , - Acta Neuropathologica Communications 2018 cited by 173

  17. Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Perneczky, Boris‐Stephan Rauchmann, Stefan Teipel, Ingo Kilimann, Doreen Göerß, Christoph Laske, Matthias H. Munk, Emrah Düzel, Renat Yakupov, Laura Dobisch, Coraline D. Metzger, Wenzel Glanz, Michael Ewers, Peter Dechent, John­–Dylan Haynes, Klaus Scheffler, Nina Roy, Ayda Rostamzadeh, Charlotte E. Teunissen, Natalie L. Marchant, Annika Spottke, Mathias Jucker, Eicke Latz, Michael Wagner, David Mengel, Matthis Synofzik, Frank Jessen, Alfredo Ramı́rez, Agustı́n Ruiz, Michael T. Heneka - Neuron 2022 cited by 64

  18. Neurochemical diagnosis of Alzheimer’s dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau

    Authors: , , , , , , , , , , , - Neurobiology of Aging 2003 cited by 311

  19. Novel Exosome Biomarker Candidates for Alzheimer’s Disease Unravelled Through Mass Spectrometry Analysis

    Authors: , , , , , , , , , , , - Molecular Neurobiology 2022 cited by 41

  20. A combined miRNA–piRNA signature to detect Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Translational Psychiatry 2019 cited by 126

  21. Serum neurofilament light chain in behavioral variant frontotemporal dementia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sandrine Bisenius, Emily Feneberg, Sibylle Haefner, Elisabeth Kasper, Delia Kurzwelly, Leonie Lampe, Johannes Levin, Finn Lornsen, Maxine Luley, Timo Jan Oberstein, Hannah Pellkofer, Catharina Prix, Tanja Richter‐Schmidinger, Nina Roth, Osama Sabri, Lisa Schachner, Robert Schomburg, Sonja Schönecker, Katharina Schuemberg, Annika Spottke, Stefan Teipel, Petra Wilken, Heike Zech - Neurology 2018 cited by 118

  22. Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clive Holmes, David Mann, A. David Smith, Seth Love, Patrick G. Kehoe, Simon Mead, Nick C. Fox, Martin N. Rossor, John Collinge, Wolfgang Maier, Frank Jessen, Britta Schürmann, Hendrik van den Bussche, Isabella Heuser, Oliver Peters, Johannes Kornhuber, Jens Wiltfang, Martin Dichgans, Lutz Frölich, Harald Hampel, Michael Hüll, Dan Rujescu, Alison Goate, John Kauwe, Carlos Cruchaga, Petra Nowotny, John C. Morris, Kevin H. Mayo, Gill Livingston, Nicholas Bass, Hugh Gurling, Andrew McQuillin, Rhian Gwilliam, Panos Deloukas, Ammar Al‐Chalabi, Christopher E. Shaw, Andrew B. Singleton, Rita Guerreiro, Thomas W. Mühleisen, Markus M. Nöthen, Susanne Moebus, Karl‐Heinz Jöckel, Norman Klopp, H.‐Erich Wichmann, E. Rüther, Minerva M. Carrasquillo, V. Shane Pankratz, Steven G. Younkin, John Hardy, Michael O’Donovan, Michael J. Owen, Julie Williams - PLoS ONE 2010 cited by 614

  23. Flavonoids as Therapeutic Compounds Targeting Key Proteins Involved in Alzheimer’s Disease

    Authors: , , , , - ACS Chemical Neuroscience 2013 cited by 190

  24. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexandre de Mendonça, Dina Silva, Gaël Chételat, Stéphanie Egret, Sebastian Palmqvist, Oskar Hansson, Pieter Jelle Visser, Johannes Berkhof, Wiesje M. van der Flier - The Lancet Neurology 2019 cited by 145